To ensure the quality and safety of medical services in primary healthcare institutions, China’s National Health Commission (NHC) and other relevant authorities issued a notice on 1 April 2026, outlining a three-year nationwide action.

Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Visby Medical announced on Friday that it will execute a $25.5 million contract option with the Office of the Assistant Secretary for Preparedness and Response to develop an at-home version of its handheld, PCR-based test for influenza and COVID-19.

On March 23, after review by the State Food and Drug Administration, two COVID-19 antigen detection reagent products were approved. As of March 23, the State Food and Drug Administration has approved 19 new coronavirus antigen detection reagent products.

Roche said on Friday that it has entered into a collaboration with Bristol Myers Squibb to develop and deploy two assays with new digital pathology algorithms for clinical trials.

Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology.

On March 21, the British Gov. web announced that three procurement contracts for COVID-19 antigen reagents.

California diagnostic firm Innova Medical Group announced on Wednesday that its Innova SARS-CoV-2 Antigen Rapid Qualitative Test has received CE marking for self-testing.

Researchers at Queen Mary University of London have developed the world’s first PCR test for mouth cancer.

On March 23, 2022, AutoBio’s SARS-CoV-2 Ag Rapid Home Test successfully passed the European clinical assessment and the audit of the notified institution, obtained the EU CE certificate.

The US Food and Drug Administration this week granted separate Emergency Use Authorizations for three direct-to-consumer SARS-CoV-2 tests from Quest Diagnostics, as well as a home sample collection kit for use with the tests.

Thermo Fisher Scientific said on Wednesday that it has been collaborating with Helix and Rosalind to develop a new genotyping method for SARS-CoV-2 that aims to speed up the identification of emerging new variants of the virus.